Charles Gomes

Charles Gomes

Active Director Designated Partner DIN 07576340
DIN 07576340 First appointment Nov 2016 Primary industry General Business
View timeline Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 0 historical roles
Total affiliations 1 Since Nov 2016
Shareholding value Locked Premium profile

About Charles Gomes

Charles Gomes has 9 years in corporate governance. Holds Designated Partner role. Currently with 1 company, including Lint Pharmaceuticals Llp. Engaged in General Business. Contributes to corporate operations.

DIN 07576340
Primary Designation Designated Partner
First Appointment 10 Nov 2016
Oldest Company Age 9 yrs

Current companies

Company Designation Appointment Founded Status
Designated Partner 10 Nov 2016 2016 Active

Previous companies

No previous companies available.

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Lint Pharmaceuticals Llp
Premium access

Shareholding and investment profile for Charles Gomes

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Charles Gomes

Charles Gomes has 9 years in corporate governance. Holds Designated Partner role. Currently with 1 company, including Lint Pharmaceuticals Llp. Engaged in General Business. Contributes to corporate operations.

Charles Gomes is associated with 1 company as Designated Partner.

Charles Gomes has expertise in General Business.

Charles Gomes has 9 years in corporate governance.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available